EUVIMEDEUVIMED entdecken
Crossref

O2 Innate immune dysregulation drives recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma

Madalina Alexandru, Imogen R Brooks, Xinyi Chen, Veronika Moravkova, Nadira Ali, John A McGrath, Jemima E Mellerio, Sophia N Karagiannis, Joanna Jacków-Malinowska

British Journal of Dermatology · 23.06.2026 · 195 (1)

DOI: 10.1093/bjd/ljag151.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 23.06.2026. Verfasst von Madalina Alexandru und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and aims Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited, immunologically active, skin disorder, characterized by skin fragility and chronic inflammation, predisposing patients to aggressive early-onset squamous cell carcinoma (cSCC). Despite this, immunopathogenic mechanisms driving tumour progression remain poorly understood, while current treatments fail to address cancer initiation. This study aimed to characterize the RDEB-cSCC innate immune landscape to identify targetable pathways for therapeutic intervention.

Methods

We performed an integrated immune analysis using bulk RNA sequencing of matched nonlesional, perilesional and lesional biopsies as a strategy to model disease progression. This was complemented by peripheral blood immunophenotyping of healthy donors, patients with RDEB and patients with RDEB-cSCC to identify innate immune alterations associated with disease severity. To validate therapeutic targets, a patient-derived three-dimensional immunocompetent spheroid model was established, designed to recapitulate key tumour-promoting immune features, observed in patients with RDEB-cSCC.

Results

Transcriptomic profiling revealed a severity-dependent macrophage enrichment and activation of the immunoregulatory pathway, Janus kinase/signal transducer and activator of transcription (JAK/STAT)3, previously identified as a promising target in RDEB-cSCC. Lesional tissue and patient plasma exhibited concurrent upregulation of both pro- and anti-inflammatory cytokine signatures, indicating a dysregulated immune response. Peripheral immune profiling further revealed a significant shift towards alternatively activated monocytes, expressing CD163 and Tim4, suggesting a prepriming of precursor tumour-associated macrophages, linked to aggressive disease progression. Uniform manifold approximation and projection analysis identified unique monocyte clusters specific to RDEB-cSCC, associated with aggressive tumour behaviour. To functionally validate these tumour-promoting immune features, an immunocompetent spheroid model was developed recapitulating protumour macrophage differentiation and cytokines release associated with JAK/STAT3 activation. Targeting the model with the clinically approved JAK1/2 inhibitor, ruxolitinib, resulted in reduced spheroid growth, increase necrosis and a significant shift in monocyte polarization towards antitumour phenotype.

Conclusions

These findings highlight the innate immune dysregulation as a central driver of RDEB-cSCC, and targeting the monocyte–macrophage plasticity via the JAK/STAT3 pathway could be a potential early intervention strategy for treating RDEB-cSCC.

Zitieren

APA

Alexandru, M., Brooks, I. R., Chen, X., Moravkova, V., Ali, N., McGrath, J. A., Mellerio, J. E., Karagiannis, S. N., & Jacków-Malinowska, J. (2026). O2 Innate immune dysregulation drives recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. British Journal of Dermatology, 195(1). https://doi.org/10.1093/bjd/ljag151.002

Vancouver

Alexandru M, Brooks IR, Chen X, Moravkova V, Ali N, McGrath JA, et al. O2 Innate immune dysregulation drives recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. British Journal of Dermatology. 2026;195(1). doi:10.1093/bjd/ljag151.002

BibTeX
@article{Alexandru2026,
  author = {Alexandru, Madalina and Brooks, Imogen R and Chen, Xinyi and Moravkova, Veronika and Ali, Nadira and McGrath, John A and Mellerio, Jemima E and Karagiannis, Sophia N and Jacków-Malinowska, Joanna},
  title = {O2 Innate immune dysregulation drives recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma},
  journal = {British Journal of Dermatology},
  year = {2026},
  volume = {195},
  number = {1},
  doi = {10.1093/bjd/ljag151.002}
}
Kostenlos starten →